Cargando…
Comparative study of amrutbhallataka and glucosamine sulphate in osteoarthritis: Six months open label randomized controlled clinical trial
BACKGROUND: AmrutBhallatak (ABFN02), a ‘rasayana’ drug from Ayurveda is indicated in degenerative diseases and arthritis. OBJECTIVE: To evaluate safety and efficacy of ABFN02 in osteoarthritis (OA) and compare it with Glucosamine sulphate (GS) MATERIALS AND METHODS: This was a randomized open compar...
Autores principales: | Raut, Ashwinikumar, Bichile, Lata, Chopra, Arvind, Patwardhan, Bhushan, Vaidya, Ashok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891179/ https://www.ncbi.nlm.nih.gov/pubmed/24459390 http://dx.doi.org/10.4103/0975-9476.123708 |
Ejemplares similares
-
A Randomized Controlled Exploratory Evaluation of Standardized Ayurvedic Formulations in Symptomatic Osteoarthritis Knees: A Government of India NMITLI Project
por: Chopra, Arvind, et al.
Publicado: (2011) -
Symptoms-modifying effects of electromotive administration of glucosamine sulphate among patients with knee osteoarthritis
por: Onigbinde, Ayodele Teslim, et al.
Publicado: (2018) -
Glucosamine sulphate: an umbrella review of health outcomes
por: Veronese, Nicola, et al.
Publicado: (2020) -
Acharya D. S. Antarkar: A Vaidya with a vision
por: Vaidya, Rama Ashok, et al.
Publicado: (2010) -
Post-COVID-19 rethinking for a synergic vision of health-care
por: Vaidya, Ashok DB., et al.
Publicado: (2020)